Status:

TERMINATED

Phase II Study to Standardize Allergen Extracts: Determination of Biological Activity in HEP Units

Lead Sponsor:

University of Zurich

Conditions:

Allergy

Eligibility:

All Genders

18-65 years

Phase:

PHASE2

Brief Summary

Today a variety of diagnostic tools to detect allergenic agents are available such as skin tests, provocation tests and blood tests. Due to its high sensitivity and low costs the skin prick test is th...

Eligibility Criteria

Inclusion

  • Inclusion criteria:
  • 18-65 years old,
  • a positive clinical history for inhalant allergy to at least one of the allergens to be tested,
  • at least one positive prick test (mean wheal diameter = 3mm) when tested with already standardized extracts of the allergens under investigation.
  • a mean wheal size of = 7mm2 obtained in a prick test with histamine dihydrochloride (10mg/ml).
  • Written informed consent
  • Exclusion criteria: -currently suffering from allergy symptoms,
  • history of systemic reactions to allergens,
  • severe diseases influencing the results of the present study by discretion of the investigator,
  • immunotherapy with an allergen preparation known to interfere with the allergens under investigation during the past two years,
  • skin lesions in the skin test areas
  • pregnancy or nursing,
  • treatment with prohibited concomitant medications (antihistamines, corticosteroids, anti-depressants, neuroleptics or specific immunotherapy)
  • alcohol or drug abuse,
  • impaired in understanding nature, meaning and the scope of the study or are incapable of giving written informed consent,
  • Participation in another clinical trial within the last 30 days.

Exclusion

    Key Trial Info

    Start Date :

    August 1 2009

    Trial Type :

    INTERVENTIONAL

    Allocation :

    ESTIMATED

    End Date :

    January 1 2011

    Estimated Enrollment :

    160 Patients enrolled

    Trial Details

    Trial ID

    NCT01412528

    Start Date

    August 1 2009

    End Date

    January 1 2011

    Last Update

    August 9 2011

    Active Locations (1)

    Enter a location and click search to find clinical trials sorted by distance.

    Page 1 of 1 (1 locations)

    1

    Clinical Trials Center

    Zurich, Switzerland

    Phase II Study to Standardize Allergen Extracts: Determination of Biological Activity in HEP Units | DecenTrialz